Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease
疾病中内在无序蛋白质的单分子生物物理学
基本信息
- 批准号:10305403
- 负责人:
- 金额:$ 3.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract: Intrinsically disordered proteins (IDPs) are found in over 50% of human proteins where they play essential roles
in a wide range of cellular functions including transcriptional regulation, DNA repair, cell signaling, and apoptosis. As a
result of their importance in key processes associated with cellular growth, proliferation, and death, proteins containing
IDPs are often associated with cancer. The ability of IDPs to adopt a wide range of conformations raises a number of key
challenges to standard biochemical, biophysical, and computational techniques. Despite these challenges, our ability to treat
many cancers depends on an understanding of the molecular basis for diseases. This, in turn, presents a pressing need to
understand the mechanistic basis of IDP function and dysfunction. This proposal will study protein-nucleic acid interactions
driven by intrinsically disordered proteins in two pressing diseases: COVID-19 and cancer. For the F99 phase (Aim 1) of
the award, I will build upon my computational and experimental biophysics training to continue investigating the SARS-
CoV-2 nucleocapsid protein and its ability to package its viral genome. The COVID-19 pandemic, preceded by previous
coronavirus outbreaks caused by SARS and MERS, necessitates study of these viruses in order to better combat them.
Coronaviruses contain large RNA genomes that are packaged into a relatively small virion, mediated by the nucleocapsid
protein, a highly disordered multidomain RNA binding protein. A current outstanding question is how SARS-CoV-2
package their 30 kb genomes into a relatively small (<100 nm) virion. The conserved structural motifs in coronavirus
genomes known as packaging signals has been shown to confer genome specificity, yet the relationship between packaging
signals and genome compaction are opaque. My thesis work combines single-molecule fluorescence spectroscopy with all-
atom and coarse-grained simulations to construct a mechanistic understanding of how N protein drives RNA packaging.
Success of this project will reveal the role of IDP-encoded multivalency in selective genome packaging. Since the
architecture of the nucleocapsid protein is conserved throughout coronaviruses it will also present new insight into
mechanisms that can be broadly targeted for therapeutic intervention. The K00 phase (Aim 2) of this proposal will study
the contribution of IDPs in transcriptional regulation, genome organization and cancer development. Fusion-oncogenes are
a common genetic translocation event which often involve a DNA binding domain becoming fused to an IDP. During the
post-doctoral phase I will obtain training in super-resolution microscopy to investigate the effects of transcriptionally active
fusion-oncogenes. Several studies have shown that IDPs from transcription factors drive the formation of transcriptional
assemblies (transcriptional condensates) at sites of gene expression. I will test the hypothesis that fusion-oncoproteins lead
to the formation of long-lived aberrant transcriptional condensates that drive the expression of proliferative genes. This will
provide direct mechanistic insight into the molecular basis of fusion-oncogene driven cancers. These combined training
plans will prepare me for a successful research career using quantitative biophysical and single-molecule techniques in the
field of mechanistic cancer biology.
摘要:在超过50%的人类蛋白质中发现了本质上无序的蛋白质(IDP),它们起着重要的作用
在广泛的细胞功能中,包括转录调节,DNA修复,细胞信号传导和凋亡。作为
它们在与细胞生长,增殖和死亡相关的关键过程中重要性的结果,含有蛋白质的蛋白质
IDP通常与癌症有关。 IDP采用广泛构象的能力提高了许多关键
标准生化,生物物理和计算技术的挑战。尽管面临这些挑战,但我们的治疗能力
许多癌症取决于对疾病分子基础的理解。反过来,这迫切需要
了解IDP功能和功能障碍的机械基础。该建议将研究蛋白质核酸相互作用
在两种压力疾病中的内在无序蛋白质驱动:COVID-19和癌症。对于F99阶段(目标1)
该奖项,我将基于我的计算和实验性生物物理学培训,以继续研究SARS-
COV-2 Nucleocapsid蛋白及其包装病毒基因组的能力。互联19大流行,之前
SARS和MERS引起的冠状病毒爆发需要研究这些病毒,以便更好地对抗它们。
冠状病毒含有大的RNA基因组,这些基因组被包装到相对较小的病毒体中,由Nucleocapsid介导
蛋白质,一种高度无序的多域RNA结合蛋白。当前的一个杰出问题是SARS-COV-2如何
将他们的30 kb基因组打包成一个相对较小的(<100 nm)的病毒粒子。冠状病毒中保守的结构基序
已证明称为包装信号的基因组赋予基因组特异性,但包装之间的关系
信号和基因组压实是不透明的。我的论文工作结合了单分子荧光光谱和
原子和粗粒模拟,以构建对N蛋白如何驱动RNA包装的机械理解。
该项目的成功将揭示IDP编码的多价性在选择性基因组包装中的作用。自从
Nucleocapsid蛋白的结构在整个冠状病毒中都保存下来
可以广泛针对治疗干预的机制。该提案的K00阶段(AIM 2)将研究
IDP在转录调节,基因组组织和癌症发展中的贡献。融合融合基因是
一个常见的遗传易位事件,通常涉及DNA结合结构域与IDP融合。在
博士后I将获得超分辨率显微镜的训练,以研究转录活性的影响
融合融合。几项研究表明,来自转录因子的IDP驱动转录的形成
基因表达部位的组件(转录冷凝)。我将测试融合 - 共蛋白铅的假设
形成驱动增殖基因表达的长寿命异常转录缩合物。这会
提供直接的机械洞察力,以了解融合 - 癌基因驱动的癌症的分子基础。这些结合培训
计划将使用定量的生物物理和单分子技术为成功的研究职业做好准备
机械癌症生物学领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Jhullian Jamille A...的其他基金
Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease
疾病中内在无序蛋白质的单分子生物物理学
- 批准号:1081866710818667
- 财政年份:2021
- 资助金额:$ 3.15万$ 3.15万
- 项目类别:
Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease
疾病中内在无序蛋白质的单分子生物物理学
- 批准号:1047383110473831
- 财政年份:2021
- 资助金额:$ 3.15万$ 3.15万
- 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Translational Regulation of SARS-CoV-2 in response to viral S protein-induced signaling
SARS-CoV-2 响应病毒 S 蛋白诱导信号传导的翻译调控
- 批准号:1072110110721101
- 财政年份:2023
- 资助金额:$ 3.15万$ 3.15万
- 项目类别:
Single Molecule Biophysics of Intrinsically Disordered Proteins in Disease
疾病中内在无序蛋白质的单分子生物物理学
- 批准号:1081866710818667
- 财政年份:2021
- 资助金额:$ 3.15万$ 3.15万
- 项目类别:
Amyloid-inspired Vaccine Delivery for the Elderly
为老年人提供淀粉样蛋白疫苗
- 批准号:1030084810300848
- 财政年份:2021
- 资助金额:$ 3.15万$ 3.15万
- 项目类别:
Project 2. cGMP manufacture of HIV-1 Env trimer sortase A-conjugated nanoparticles
项目2. HIV-1 Env三聚体分选酶A结合纳米颗粒的cGMP生产
- 批准号:1054186810541868
- 财政年份:2021
- 资助金额:$ 3.15万$ 3.15万
- 项目类别:
Project 2. cGMP manufacture of HIV-1 Env trimer sortase A-conjugated nanoparticles
项目2. HIV-1 Env三聚体分选酶A结合纳米颗粒的cGMP生产
- 批准号:1036907010369070
- 财政年份:2021
- 资助金额:$ 3.15万$ 3.15万
- 项目类别: